在学龄儿童中严重喘:对这个年龄组的生物选择和挑战的最新评估
Cristiana Indolfi1, Angela Klain1, Maria Cristina Capuano1
1Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy.
Children (Basel, Switzerland)
|February 26, 2025
概括
像梅波利祖马布和奥马利祖马布这样的生物疗法为重症儿科喘 (T2高喘) 提供了新的希望. 本综述涵盖了它们的好处,安全性和挑战,包括有效治疗的成本和患者选择.
科学领域:
- 儿科肺病学 儿科肺病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在儿童 (6-11岁) 中,严重的喘带来了重大的临床挑战.
- 目前的管理策略往往不足以应对严重病例.
- 生物疗法代表了儿科喘护理中的范式转变.
研究的目的:
- 审查严重儿科喘生物疗法的当前作用和新兴潜力.
- 评估6至11岁儿童生物治疗的疗效,安全性和实际考虑.
- 探索未来的方向,包括用于个性化治疗的新药和生物标志物.
主要方法:
- 临床试验和观察性研究的文献综述关于严重儿科喘的生物疗法.
- 对疗效,安全性,耐受性和成本效益的数据进行分析.
- 检查当前的指导方针和未来的研究趋势.
主要成果:
- 梅波利祖马布,奥马利祖马布和杜比卢马布在儿童T2高的严重喘中有效.
- 这些生物药物表现出良好的安全性,但监测至关重要.
- 挑战包括成本,坚持和确定最佳患者候选人.
- 德泽佩卢马布在T2低喘中显示出前景,扩大了治疗选择.
结论:
- 生物疗法对于治疗严重的儿科喘,特别是T2高的表型越来越重要.
- 使用生物标志物的个性化治疗方法对于最大限度地提高治疗效益至关重要.
- 目前正在进行的研究和开发正在扩大儿童喘生物治疗的范围.
- 解决实际挑战是成功实施这些先进疗法的关键.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
226
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
226
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
326
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
326
Antiasthma Drugs: β2-Adrenoceptor Agonists
226
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
226


